Concepedia

Natarajan Muthusamy

NM

Statistics

Publications

109

Citations

9.4K

H-Index

51

Active since

1988

Affiliations

The Ohio State University(Current)

University of Kentucky

Markey Cancer Center

American Association of Colleges of Pharmacy

Natarajan Muthusamy is an author at The Ohio State University specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1988–2023

109

Publications

109

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 783 citations · Full text

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1

Ramiro Garzon, Shujun Liu, Muller Fabbri et al. · Blood · 2009 · 768 citations · Full text

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

Joseph A. Fraietta, Kyle A. Beckwith, Prachi Patel et al. · Blood · 2016 · 450 citations · Full text

Ibrutinib treatment improves T cell number and function in CLL patients

Meixiao Long, Kyle A. Beckwith, Priscilla Do et al. · Journal of Clinical Investigation · 2017 · 362 citations · Full text

The Ets-1 Transcription Factor Is Required for the Development of Natural Killer Cells in Mice

Kevin Barton, Natarajan Muthusamy, Christopher Fischer et al. · Immunity · 1998 · 354 citations · Full text

, , +6

1–5 of 109